|
PTPN14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.005980E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.971700E-02 |
| Normal-vs-Stage2 |
1.486200E-02 |
| Normal-vs-Stage3 |
7.663700E-03 |
| Normal-vs-Stage4 |
1.572110E-02 |
| Stage1-vs-Stage2 |
3.843600E-01 |
| Stage1-vs-Stage3 |
5.871200E-01 |
| Stage1-vs-Stage4 |
6.028400E-01 |
| Stage2-vs-Stage3 |
6.315000E-01 |
| Stage2-vs-Stage4 |
7.530000E-01 |
| Stage3-vs-Stage4 |
8.750200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.918180E-02 |
| Normal-vs-AfricanAmerican |
9.997600E-01 |
| Normal-vs-Asian |
3.953500E-02 |
| Caucasian-vs-AfricanAmerican |
1.096600E-01 |
| Caucasian-vs-Asian |
7.880800E-01 |
| AfricanAmerican-vs-Asian |
1.615360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.15879999999813E-05 |
| Normal-vs-Female |
2.115600E-02 |
| Male-vs-Female |
1.049630E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.987600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.589630E-02 |
| Normal-vs-Age(61-80Yrs) |
3.022200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.642200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.583800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.153800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.222400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.491000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.053500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.463800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.273970E-02 |
| Classical-VS-Follicular |
1.43289999998686E-06 |
| Classical-VS-Other |
1.405240E-01 |
| Classical-VS-Normal |
1.655370E-01 |
| Tall-VS-Follicular |
1.233030E-01 |
| Tall-VS-Other |
2.772000E-01 |
| Tall-VS-Normal |
1.476910E-03 |
| Follicular-VS-Other |
8.879800E-01 |
| Follicular-VS-Normal |
1.086000000039E-06 |
| Other-VS-Normal |
1.888200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.938170E-03 |
| Normal-vs-N1 |
2.038300E-02 |
| N0-vs-N1 |
6.335200E-01 |
|
|
